Deleted FY 2027 ICD-10-PCS Procedure Codes ICD-10-PCS
The FY 2027 ICD-10-PCS update deletes 40 procedure codes, effective October 1, 2026. New Technology leads with 38 of them. Every deleted code is listed below by section, with a filter to find the ones that matter to you.
Sections with no deleted codes in this release are omitted. Counts from the official FY 2027 release files.
Section 3: Administration 2 deleted
Section X: New Technology 38 deleted
| Code | Description |
|---|---|
| X2KB317 | Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 |
| X2KC317 | Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 |
| XD2G4V7 | Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XD2G8V7 | Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 |
| XD2H4V7 | Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XD2H8V7 | Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 |
| XRGA0R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGA3R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGA4R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGB0R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGB3R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGB4R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGC0R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGC3R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGC4R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGD0R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGD3R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGD4R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XW00X27 | Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7 |
| XW01397 | Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 |
| XW01X27 | Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7 |
| XW023X7 | Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 |
| XW03367 | Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW03377 | Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW03387 | Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW033B7 | Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW04367 | Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW04377 | Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW04387 | Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW043B7 | Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW0DXR7 | Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 |
| XW0G7R7 | Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 |
| XW0H7R7 | Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7 |
| XW133D7 | Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW133F8 | Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW143D7 | Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XXE5XR7 | Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7 |
| XXE5XT7 | Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7 |
FY 2027 Deleted Codes FAQ
How many ICD-10-PCS codes were deleted for FY 2027?
The FY 2027 release deletes 40 procedure codes across 2 sections. Deletions are routine code set maintenance, often retiring New Technology codes whose procedures moved into the standard sections.
Can I still report a deleted procedure code?
Only for hospital discharges before October 1, 2026. From that date forward, claims using a deleted code will be rejected, so facility charge masters and encoder shortcuts need to be remapped to the replacement codes.
When do the FY 2027 codes take effect?
The FY 2027 procedure code set applies to hospital discharges from October 1, 2026 to September 30, 2027. ICD-10-PCS follows the federal fiscal year, with the update taking effect on October 1.
Related References
Source: official FY 2027 ICD-10-PCS release files published by the Centers for Medicare & Medicaid Services (CMS), effective October 1, 2026 – September 30, 2027.